Anita Afzali, MD, MPH, FACG
University of Cincinnati
Cincinnati, OH

As executive vice chair, Dr. Afzali will be the clinical leader for the Department of Internal Medicine and provide oversight for clinical operations within UC Physicians and UC Health. She will oversee the clinical components of the department that integrate with the College of Medicine, UC Physicians, UC Health, Cincinnati Children’s, and Cincinnati Veterans Affairs Medical Center. Additionally, she will work with senior leadership within the department and at UC Health to increase clinical volume, provide administrative oversight for all advanced practice providers in the department and work closely with the faculty of the college, clinical staff, and UC Health to ensure safe and effective care is provided to patients across all internal medicine subspecialties.

Cincinnati, OH

 Anita Afzali, Christopher J. Park, Kehao Zhu, Jie Kate Hu, Prachi Sharma, Mika N. Sinanan, Scott D. Lee. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2016 August; 22(8): 1887-1895.

 Ryan B. O’Malley, Neil J. Hansen, Jonathan Carnell, Anita Afzali, Mariam Moshiri. Update on MR Enterography: Potentials and Pitfalls. Current Radiology Reports. 2016 June, 4(8): 1-17.

 Anita Afzali and Raymond K Cross. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A systematic review of disease characteristics and differences. Inflammatory Bowel Diseases. 2016 August; 22(8): 2023-2040.

 Anita Afzali. Pediatric to Adult Transition of Care in Inflammatory Bowel Disease: A common and necessary process. World Gastroenterology Organization, e-WGN. www.worldgastroenterology.org (November 2016, Volume 21, Issue 3).

 Anita Afzali, Kristine Ogden, Michael L. Friedman, Jingdong Chao, Anthony Wang. Costs of Providing Infusion Therapy for Patients with Inflammatory Bowel Disease in a Hospital-based Infusion Center Setting. Journal of Medical Economics. 2017 January; 23: 1-35.

 Anita Afzali and Ghassan Wahbeh. Transition of Pediatric to Adult Care in Inflammatory Bowel Disease: Is it as easy as 1, 2, 3? World Journal of Gastroenterology. 2017 May; 23: 3624-3631.

 William J. Sandborn, Douglas C. Wolf, Gordana Kosutic, Gerry Parker, Stefan Schreiber, Scott D. Lee, Bincy Abraham, Anita Afzali, Razvan I. Arsenescu, Alexandra Gutierrez, Marshall Spearman, Jason Coarse and Brian G. Feagan. Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data From a 7-Year Study in Crohn’s Disease. Inflammatory Bowel Diseases. 2017 July; 23:1047-1056.

 MEB Clowse, AE Scheuerle, C. Chambers, Anita Afzali, AB Kimball, JJ Cush, M. Cooney, L Shaughnessy, M. Vanderkelen and F. Foger. Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from a Pharmacovigilance Safety Database. Arthritis & Rheumatology. 2018 September; 70(9): 1399-1407.

 Anita Afzali, Matthew A Ciorba MD, David A. Schwartz MD, Mai Sharaf MD, Chris Fourment MD, Timothy Ritter MD, Douglas C. Wolf MD, Ira Shafran MD, Charles W. Randall MD, Sunanda V Kane MD, MSPH. Challenges in Using Real-World Clinical Practice Records for Validation of Clinical Trial Data in Inflammatory Bowel Disease: Lessons Learned. Inflammatory Bowel Diseases 2018; 24: 2-4.

 Evan Tiderington, Anita Afzali. Approach to Management of the Patient with IBD Following TNF Inhibitor Failure. Journal of Clinical Outcomes Management. 2018 May; 25(5):219-228.

 Anita Afzali and Seymour Katz. Inflammatory Bowel Disease in the Baby to Baby Boomer: Pediatric and Elderly onset of IBD. Current Treatment Options in Gastroenterology. 2018 September; 16:289-305.

 Kruger AJ, Hinton A, Afzali A. Index severity score and early readmission predicts increased mortality in ulcerative colitis patients. Inflammatory Bowel Diseases. 2019 April; 25(5): 894-901.

 Afzali, A. Inflammatory Bowel Disease: Management of the pregnant patient in disease flare or remission. Current Treatment Options in Gastroenterology. 2019 April; 35: 281-87.

 Alley K, Singla A, Afzali A. Opioid use is associated with higher health care costs and emergency encounters in inflammatory bowel disease. Inflammatory Bowel Diseases. 2019 May (epub).

 Kruger AJ, Hinton A, Afzali A. To The Editors: Index Severity Score and Early Readmission Predicts Increased Morality in Crohn’s Disease Patients. Inflammatory Bowel Diseases. 2019 June; 25(7): e74-76.

 Chen T, Shi N, Afzali A. Chemopreventive effects of strawberry and black raspberry on colorectal cancer in inflammatory bowel disease. Nutrients 2019 June; 11(6) (epub).

 Afzali, A. Update on Pregnancy in Patients with Inflammatory Bowel Disease. Gastroenterology & Hepatology 2019 June; 15:313-315

 McMahon KR, Allen KD, Afzali A, Husain S. Predicting post-operative complications in Crohn’s disease: an appraisal of clinical scoring systems and the NSQIP surgical risk calculator. Journal of Gastrointestinal Surgery 2019 Aug (epub).

 Menon, Tara and Afzali, Anita. Inflammatory Bowel Disease: A Practical Path to Transitioning from Pediatric to Adult Care. American Journal of Gastroenterology. 2019 September; 114(9): 1432-1440 .

 Menon, Tara and Afzali, Anita. Immune-mediated Colitis. Current Treatment Options in Gastroenterology. 2019 November; 1-18 (epub).

Content available soon!

    Webcasts

    Impact of IBD on Healthcare Systems

    Gary Lichtenstein, MD ; David Rubin, MD ; Bruce Sands, MD ; Brennan Spiegel, MD ; Douglas Wolf, MD

    Didactic Lecture

    view details >

    eMonograph

    GI Alliance Payer Summit

    view details >

    Clinical and Managed Care Perspectives in Inflammatory Bowel Disease: Closing the Gap

    view details >

    Addressing Health Outcomes and Rising Costs in the Management of Inflammatory Bowel Disease

    view details >

    The Guide to Guidelines in IBD: Interpretation and Appropriate Use in Clinical Practice

    view details >

    INFORM UC: An Update on Contemporary Management of UC

    view details >

    Breaking The Barriers: Improving Access to Biologic Therapies in IBD

    view details >

    IBD Management: State of the Art in 2018

    view details >

    Improving IBD Care A Personalized Approach to Management

    view details >

    Expert Perspectives in the Management of Inflammatory Bowel Disease (IBD): A Review of Recent Advances

    view details >

    Advances in IBD

    view details >

    Optimizing the Management of Inflammatory Bowel Disease

    view details >

    Webcasts

    Impact of IBD on Healthcare Systems

    Gary Lichtenstein, MD ; David Rubin, MD ; Bruce Sands, MD ; Brennan Spiegel, MD ; Douglas Wolf, MD

    Didactic Lecture

    view details >

    Dinner Meetings

    Content available soon

    Audiocasts

    Content available soon!

    Content available soon!

    © Copyright 2013-2024 GI Health Foundation. All rights reserved.
    This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.